Investment analysts at William Blair decreased their Q2 2025 earnings estimates for HEICO in a research note issued to ...
The private equity owners of Granicus are preparing to explore a sale of the government-services software maker that could value it at about $4 billion, including debt, according to people familiar ...
Palantir shares surged Wednesday as William Blair analysts suggested the company’s software could be well positioned to support Department of Government Efficiency efforts to trim spending.
Biodesix (NASDAQ:BDSX – Get Free Report)‘s stock had its “outperform” rating restated by stock analysts at William Blair in a ...
William Blair analyst Louie DiPalma upgraded Palantir’s stock to Market Perform from Underperform on Wednesday, following a ...
Palantir (PLTR) is climbing today after the firm was upgraded by an investment bank and announced a new partnership.
It will invest in government debt from frontier markets countries across Asia, Latin Am, Eastern Europe, Middle East, Africa ...
Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...
Autism software provider CentralReach has been looking for a potential buyer, according to multiple sources with knowledge of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback